WEBSHOP
Need help? Click here to use the Duolink Kit Wizard »
Do you know what you need? Click here to order Duolink products »
Press releases from Olink Bioscience
OLINK BIOSCIENCE INTRODUCES A NEW AND IMPROVED DUOLINK PRODUCT LINE
Uppsala, Sweden, May 12, 2010 - Olink Bioscience expands its product portfolio by launching three new products, the Duolink® II reagent kit, Duolink® ImageTool, and Duolink® II Probemaker. The original Duolink product line, introduced on the market in 2007, has been well received by academic labs and pharma companies for its unique and enabling features to visualize and locate native protein-protein interactions and low abundant proteins in fixed cells and tissues. The new, updated version of the Duolink kit offers the same unique features but is faster, better and more convenient. Together with the ImageTool and Probemaker Olink Bioscience is now able to offer a complete solution, from detection to image analysis, for the protein research community where these powerful tools will help elucidate disease mechanisms and signaling pathways, leading to the development of novel diagnostics and therapeutics.
Press release New Duolink Product Line
OLINK BIOSCIENCE AND MULTISCIENCES BIOTECH SIGN DISTRIBUTION AGREEMENT
UPPSALA, Sweden, March 8, 2010-Olink Bioscience has signed a distributorship agreement with the Chinese distributor Multisciences Biotech Co., Ltd for distribution of the Duolink® product line in China.
Press release Olink and Multisciences Biotech
OLINK BIOSCIENCE AND BEIJING PIONEER SIGN DISTRIBUTION AGREEMENT
UPPSALA, SWEDEN, March 4, 2010 – Olink Bioscience has signed a distributorship agreement with Beijing Pioneer Medical Instrument Co., Ltd for distribution of the Duolink® product line in China.
Press release Olink and Pioneer Biomed
OLINK BIOSCIENCE ACQUIRES PATENTS FOR ROLLING CIRCLE AMPLIFICATION
Uppsala, Sweden, November 16, 2009– Olink Bioscience have today announced that they have expanded their patent portfolio within the field of rolling circle amplification by acquiring a family of three patents from the Danish biotech company In Situ RCP A/S.
Press release Olink Bioscience acquires patents
OLINK BIOSCIENCE AND AXXORA LLC SIGNS DISTRIBUTION AGREEMENT FOR DUOLINK IN THE NORTH AMERICAN MARKET
Uppsala, Sweden, November 9, 2009 - Olink Bioscience a Sweden based biotechnology company has entered into a distribution agreement with Axxora LLC for distribution of Olink Bioscience product line Duolink® in the North American market. Axxora, a major life science research distributor in San Diego, USA, will handle distribution and service of Olink Bioscience products.
Press release Olink Bioscience and Axxora
OLINK BIOSCIENCE APPOINTS PATRIK DAHLEN AS CHAIRMAN OF THE BOARD
Uppsala, Sweden, September 28, 2009-Olink Bioscience, a rapidly growing provider of innovative tools for proteomics and genomics, has today announced the appointment of Dr. Patrik Dahlén as Chairman of the Board. As the former CEO of global cancer diagnostics company Dako and with experience from several smaller fast developing biotech companies, Dr. Dahlén will bring invaluable industry insight and a fresh perspective to Olink Bioscience continued expansion. Professor Ulf Landegren, co-founder and the company´s former Chairman of the Board will continue to serve on the BoD and he will continue to bring the company valuable contacts with the scientific community in Uppsala and internationally.
OLINK BIOSCIENCE AND OLINK GENOMICS IN A PROJECT AIMED TO IMPROVE CANCER TREATMENT
Uppsala, Sweden, September 14, 2009 – Olink Bioscience and its sister company Olink Genomics is participating in the project “Companion Diagnostics Initiative” which is financed by Vinnova and aims to develop improved cancer diagnostics to increase survival rate of patients with colorectal cancer. The project is coordinated by Professor Mats Nilsson at the Department of Genetics and Pathology and involves several clinical and pre-clinical research groups at Uppsala University.
Press release Vinnova
OLINK BIOSCIENCE INTRODUCES A NEW TOOL TO DETECT HOMODIMERIC PROTEIN-PROTEIN INTERACTIONS
Uppsala, Sweden, September 9, 2009 - Olink Bioscience launches a new product, the Duolink® anti-Hapten PLA™ probes. The Duolink anti-Hapten product family contains PLA probes (secondary reagents) to the haptens Biotin, Fluorescein and Digoxin. Together with existing products the new Duolink PLA probes enables detection of protein-protein interactions, protein modifications and proteins in fixed cells and tissue sections.
OLINK BIOSCIENCE AND ABNOVA SIGN DISTRIBUTION AGREEMENT FOR THE NORTH AMERICAN MARKET
Uppsala, Sweden August 31, 2009 - Olink Bioscience and the Abnova Corporation have signed a distributorship agreement appointing Abnova distributor for the Duolink® in situ PLA™ product line in the USA. This agreement is an expansion of a previous co-marketing/co-development agreement under which the companies have been collaborating on the validation of hundreds of target-specific assays for studies of protein phosphorylation and protein interactions based on primary antibodies from Abnova and the Duolink product line from Olink Biosceince.
Press release Olink Bioscience and Abnova corporation
OLINK BIOSCIENCE AND GENETIX BIOTECH ASIA (P) LTD SIGN DISTRIBUTORSHIP AGREEMENT FOR THE INDIAN MARKET
UPPSALA, SWEDEN, August 20, 2009 – Olink Bioscience has signed a distributorship agreement with Genetix Biotech Asia Pvt. Ltd for distribution of the Duolink® in situ PLA™ product line in India and south East Asian countries. This region represents a new market for Olink Bioscience with an increasing number of academic and industrial customers.
Press release Olink Bioscience and Genetix
OLINK BIOSCIENCE AND AH DIAGNOSTICS SIGN DISTRIBUTOR AGREEMENT FOR THE DANISH AND NORWEIGAN MARKETS
UPPSALA, SWEDEN, August 17, 2009 – Olink Bioscience has signed a distributorship agreement with AH diagnostics for distribution of the Duolink® in situ PLA™ product line in Denmark and Norway.
Press release Olink Bioscience and AH diagnostics
OLINK BIOSCIENCE AND IMMUNO DIAGNOSTIC SIGN DISTRIBUTOR AGREEMENT FOR THE FINNISH MARKET
UPPSALA, SWEDEN, August 10, 2009- Olink Bioscience has signed a distributor agreement with Immuno Diagnostic Oy for distribution of the Duolink® in situ PLA™ product linde in Finland.
Press release Olink Bioscience and Immuno Diagnostic
OLINK BIOSCIENCE INTRODUCES A NEW WAY TO VISUALIZE PROTEINS IN TISSUE
UPPSALA, SWEDEN, May 5, 2009 – Olink Bioscience launches today a new product for detection of proteins, protein interactions and modifications in tissue samples. For the first time, results from a Duolink®assay can be analyzed and visualized with brightfield microscopy, adding a new feature to the diversity of the Duolink product family. Now, the morphology of tissue can be studied in great detail, in combination with quantification of proteins, protein complexes and protein modifications.
The new product, Duolink Detection Kit HRP/NovaRED generates discrete spots that each represents individual proteins or protein events. The spots can be counted by automated software, thereby bringing objectivity to investigations which have previously relied on subjective evaluation.
Press release Duolink Detection Kit HRP/NovaRED
OLINK BIOSCIENCE AND EUROGENTEC SIGN DISTRUBUTION AGREEMENT FOR THE EUROPEAN MARKET
UPPSALA, SWEDEN, April 21, 2009 - Olink® Bioscience has signed an agreement with Eurogentec S.A. for distribution of the Duolink® in situ PLA™ product line in major geographies in Europe. Eurogentec, headquartered in Belgium, will handle distribution and sales for Germany, France, Belgium, Luxembourg, The Netherlands, Switzerland, Austria, and the Czech Republic. This region represents an important market for Olink Bioscience with a rapidly increasing number of academic and industrial customers. Eurogentec will become the sole distributor in the region.
Press release Olink Bioscience and Eurogentec
OLINK BIOSCIENCE AND ABNOVA SIGN CO-MARKETING AGREEMENT TO PROMOTE UNIQUE TARGET-SPECIFIC ASSAYS FOR CELL SIGNALING STUDIES
Uppsala, Sweden and Taipei, Taiwan (April 16, 2009).
Olink Bioscience and Abnova Corporation today announce a co-development and co-marketing agreement. This collaboration will address the unmet need for high-performance assays for studies of protein phosphorylation and protein interactions by combining Abnova´s growing collection of +30,000 antibodies with the Duolink® product line from Olink Bioscience. Hundreds of target-specific assays will be jointly marketed by the two companies, while sales of the proprietary products will be handled by the respective companies and their distributors.
Olink Bioscience and Abnova Press Release.pdf
THE PROACTIVE CONSORTIUM GRANTED € 3M- TO DEVELOP A UNIQUE HIGH THROUGHPUT PLASMA BIOMARKER RESEARCH PLATFORM
February 16, 2009. A new consortium has been formed to build a high throughput plasma biomarker research infrastructure supported by a € 3M grant as a part of the European Commission 7th framework programme (FP7). The three year project, coordinated by Olink Bioscience (Uppsala, Sweden), will develop methods and reagents for highly multiplexed proximity ligation assays for protein detection, along with tailored statistics and data management tools. The research infrastructure will be implemented in a series of pilot biomarker projects aiming to improve colorectal cancer detection in minute blood samples.
Pressrelease PROACTIVE
READNA CONSORTIUM TO ACCELERATE DEVELOPMENT OF DNA/NUCLEIC ACID ANALYSIS TECHNOLOGIES
December 3rd 2008, A new consortium was launched today to further the development of new technologies for the analysis of DNA and other nucleic acids. The REvolutionary Approaches and Devices for Nucleic Acid analysis (READNA) consortium includes projects to accelerate new breakthrough DNA sequencing technologies and methods to enhance existing analysis methods. The consortium includes 16 European partners from both academia and industry, and launches with a €12m grant via the European Commission's seventh Framework Programme (FP71).
http://www.cng.fr/READNA/newsevents/press_dec08_en.html
OLINK JOINS FORCES WITH RESEARCHERS AT UPPSALA UNIVERSITY TO COMMERCIALIZE SAMPLE PREPARATION PRODUCTS FOR THE NEW DNA SEQUENCING PLATFORMS.
UPPSALA, Sweden, September 3rd, 2008-Olink AB, an Uppsala-based biotechnology company, announces the co-founding of Olink Genomics AB together with researchers at Uppsala University. The Olink subsidiary will commercialize the proprietary Selector Technology™ for sample preparation applications in the rapidly expanding market of next-generation DNA sequencing.
OLINK BIOSCIENCE AND SCIENTISTS AT UPPSALA UNIVERSITY FOUNDS A NEW INSTRUMENT COMPANY: Q-LINEA AB
UPPSALA, SWEDEN, 7 July 2008 - Olink AB, a Swedish biotechnology company, has recently founded the instrument company Q-linea AB together with scientists at Uppsala University and Uppsala University Holding AB.
English Svenska